Promise Tracker
0 delivered, 0 close, 2 missed.
View Promises →HDFC Life reported a solid Q4 FY25 with PAT up 15% to INR 1,802 crore, driven by strong backbook profit growth of 18%.
✓ Verified against BSE filing
HDFC Life reported a solid Q4 FY25 with PAT up 15% to INR 1,802 crore, driven by strong backbook profit growth of 18%. Individual APE grew 18% for the full year, with broad-based growth across channels and products. ULIPs remained elevated at 39% of mix, but participating products gained traction with new launches. VNB grew 13% to INR 3,962 crore, with margins at 25.6%, impacted 30bps by surrender value regulations. Management guided for a softer H1 FY26 due to base effects, with growth picking up in H2. Margins are expected to remain range-bound as the company invests in agency expansion and technology transformation (Project Inspire). Key risk: equity market volatility could pressure ULIP persistency and product mix.
HDFC Life ने वित्त वर्ष 2025 की चौथी तिमाही में अच्छा प्रदर्शन किया। कंपनी का मुनाफा (PAT) 15% बढ़कर 1,802 करोड़ रुपये हो गया, जो पुरानी पॉलिसियों से मुनाफे में 18% की बढ़ोतरी के कारण हुआ। साल भर में नए बीमा प्रीमियम (Individual APE) में 18% की वृद्धि हुई, जो सभी चैनलों और उत्पादों में फैली रही। यूनिट-लिंक्ड प्लान (ULIP) की हिस्सेदारी 39% रही, लेकिन नए प्रॉफिट-शेयरिंग उत्पादों ने लोकप्रियता पाई। नए कारोबार से मुनाफा (VNB) 13% बढ़कर 3,962 करोड़ रुपये हुआ, लेकिन मार्जिन 25.6% रहा, जो सरेंडर वैल्यू नियमों के कारण थोड़ा कम हुआ। कंपनी का अनुमान है कि अगले साल की पहली छमाही में वृद्धि धीमी रहेगी, लेकिन दूसरी छमाही में तेजी आएगी। मार्जिन स्थिर रहने की उम्मीद है क्योंकि कंपनी एजेंसी विस्तार और तकनीकी बदलाव (प्रोजेक्ट इंस्पायर) में निवेश कर रही है। मुख्य जोखिम: शेयर बाजार में उतार-चढ़ाव से ULIP पॉलिसियों की बिक्री प्रभावित हो सकती है।
0 delivered, 0 close, 2 missed.
View Promises →Equity market volatility impacting ULIP persistency
View Risks →Full transcript text is available on this route.
Read Transcript →Full-year individual APE growth, driven equally by 9% policy count increase and 9% ticket size increase.
Value of new business for FY25, reflecting growth in line with APE despite margin compression.
Margin impacted by surrender charge regulations; underlying product margins improved 40bps.
Operating return on embedded value of 16.7%, reflecting strong backbook profitability.
First half growth likely moderate due to high base of ~30% in H1 FY25; momentum expected to pick up in H2, leading to balanced full-year outcome.
Despite potential margin-accretive product mix, investments in distribution and technology will keep margins range-bound; long-term upward trajectory expected.
Aspiration to double APE, VNB, and other key metrics over four to four-and-a-half-year cohorts, implying ~16-17% CAGR.
Retail protection expected to grow faster than overall company growth in FY26, supported by product innovation and rider attachment.
Management reiterated its aspiration to achieve 18-20% annual premium equivalent growth for the full year.
Management aims to deliver value of new business growth of upwards of 15% for the full year.
Net impact of new surrender value regulations on margins expected to be 20-30 basis points on an annualized basis after distribution adjustments.
Elevated ULIP mix (39%) exposes the company to surrender risk if equity markets turn volatile, as customers may exit.
Some unlisted competitors have shown aggression post surrender value regulations, potentially pressuring pricing and margins.
Moderating GDP growth and global trade tensions could impact household savings and demand for long-term products.
Credit Protect growth has been tepid due to slower disbursements in the MFI sector, which could persist if the lending cycle does not recover.
A recent data breach was identified and addressed, but could lead to reputational damage or regulatory scrutiny if further issues emerge.
Mentioned in Q2 FY25, Q3 FY24
Aggressive pricing by peers in credit life and annuity has led to slower growth; management expects rationalization as surrender charges reduce.
Mentioned in Q2 FY24, Q3 FY24
Ticket sizes above INR 5 lakh have been slow to recover, and management's optimism about a resurgence may not materialize quickly.
Mentioned in Q1 FY25, Q4 FY24
Aggressive pricing by peers in credit life and annuity segments may pressure growth and margins; management has stepped back from unviable business.
Mentioned in Q1 FY24, Q2 FY24
Some players offer higher IRRs, potentially pressuring HDFC Life's non-par margins if they need to match pricing.
First half growth likely moderate due to high base of ~30% in H1 FY25; momentum expected to pick up in H2, leading to balanced full-year outcome.
Elevated ULIP mix (39%) exposes the company to surrender risk if equity markets turn volatile, as customers may exit.
View Risks →